Pure Pathologic Response Is Associated with Improved Overall Survival in Patients with Advanced Systemic Mastocytosis Receiving Avapritinib in the Phase I EXPLORER Study
2020
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
4
Citations
NaN
KQI